Sign inJoin waitlistJoin the waitlist

Mili Arora

Hematology & Oncology · Regents of the Univ of Ca

Credentials: · ·

History

Research

Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene
Pharmacogenomics · 2007 · 81 citations
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
npj Breast Cancer · 2022 · 56 citations
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial
Nature Medicine · 2024 · 45 citations

Candice Sauder
4 papers
Alexandra Thomas
3 papers
Amy Clark
3 papers
AS
Amy Sanford
3 papers
Angela DeMichele
3 papers
Anne Wallace
3 papers
Anthony Elias
3 papers
Christos Vaklavas
3 papers
Claudine Isaacs
3 papers
Dawn Hershman
3 papers
Douglas Yee
3 papers
Erica Stringer-Reasor
3 papers

Clinical trials

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2024–2030
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2023–2033
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Site PI · Recruiting · Phase 1
National Cancer Institute (NCI)
2022–2028
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Site PI · Recruiting · Phase 2
QuantumLeap Healthcare Collaborative
2010–2031